April 19, 2026

This article is for patients dependent on concentrated 7-hydroxymitragynine (7-OH) products — the tablets, gummies, lozenges, and shots sold at smoke shops and gas stations — who are weighing Suboxone or a long-acting buprenorphine injection as the next step. The short answer to the title question is yes. The longer answer is about timing, which matters more for 7-OH than for most other substances.

The Short Version

Buprenorphine (the active ingredient in Suboxone, Sublocade, and Brixadi) is a partial agonist at the mu-opioid receptor — the same receptor 7-OH activates. Because of that shared mechanism, buprenorphine-based MAT works for 7-OH dependence in the same way it works for heroin, fentanyl, or prescription-opioid dependence. Your brain recognizes buprenorphine is occupying the receptors 7-OH was occupying. Cravings quiet. Withdrawal stops. The daily cycle breaks.

What’s specific to 7-OH is the timing of the first dose. Because buprenorphine binds more tightly to the mu receptor than 7-OH does, taking Suboxone while there’s still meaningful 7-OH activity in the system can trigger precipitated withdrawal — a sudden, severe withdrawal that’s avoidable with correct timing.

Why 7-OH Timing Is Harder to Predict

Two things make 7-OH induction trickier than leaf kratom induction:

  • Higher potency, deeper receptor activation. Concentrated 7-OH saturates mu-opioid receptors more fully than leaf kratom or many full-agonist opioids. The longer buprenorphine waits, the more receptor space opens up for it to occupy cleanly.
  • Dosing rhythm. 7-OH concentrates are usually dosed multiple times per day because the duration of each dose is relatively short. Patients dependent on them often can’t tell the difference between “low blood level” and “withdrawal” in the first several hours of abstinence, which can lead to dosing again before the clinical window opens. Your provider will talk through your specific pattern at intake.

For whole-leaf kratom, a 12-hour wait since last dose is typically enough to reach a safe COWS score (the Clinical Opiate Withdrawal Scale, 8–12 range for induction). For concentrated 7-OH, most protocols favor at least 18 to 24 hours, and individual variation is wider.

What a Safe Induction Window Looks Like

Your provider combines two pieces of information to decide timing:

  • Time since last 7-OH dose. Reported by you at intake. Honesty here matters more than anything else — under-reporting the last use puts you at direct risk of precipitated withdrawal.
  • Your COWS score. A structured clinical measurement of observable withdrawal signs (pupil size, sweating, tremor, gooseflesh, anxiety, gastrointestinal upset, restlessness). A score of 8 or higher is the typical minimum before first buprenorphine dose; many providers prefer 12 or higher for 7-OH patients to add margin.

If your COWS score is in range at intake, induction happens that day. If it isn’t, the clinician will either reschedule you for later in the day or the next day, or consider a micro-induction protocol (below) rather than have you white-knuckle through more unstructured withdrawal at home.

What Is Micro-Induction?

Micro-induction (also called the Bernese method in some clinical literature) is a newer protocol for starting buprenorphine when the conventional “wait for moderate withdrawal” approach is hard to execute — for example, after long-acting opioids, fentanyl, or concentrated 7-OH products where the wait window is long, uncomfortable, or unpredictable.

Instead of waiting for a COWS score of 8–12 before a single standard-size dose, micro-induction uses very small buprenorphine doses titrated over several days, while the patient may continue to use their existing opioid at reducing amounts. The small buprenorphine doses are below the threshold at which displacement occurs, so they don’t trigger precipitated withdrawal even while the other opioid is still present. Over the course of three to seven days, the buprenorphine dose climbs to a therapeutic level and the other opioid is tapered out.

Micro-induction isn’t always needed for 7-OH. Many patients do fine with a conventional induction at 18–24 hours of abstinence. Your provider decides based on your specific use pattern, dose, and tolerance.

What Happens If the Timing Is Off?

Precipitated withdrawal — the bad outcome timing is designed to prevent — feels like the worst version of natural opioid withdrawal: nausea, vomiting, diarrhea, body aches, anxiety, restlessness, sweating, cramps, all at once, usually within an hour of dosing. Unlike natural withdrawal, which ramps up over 8 to 24 hours, precipitated withdrawal comes on fast and hard.

It resolves on its own within four to six hours as receptor occupancy stabilizes, and it is not dangerous in the medical sense — but it is deeply unpleasant and a common reason patients distrust the medication for weeks afterward. The clinically correct response in most cases is to give more buprenorphine, not less, because full receptor occupancy quiets the withdrawal faster than waiting for drug levels to shift. Your provider will manage this if it happens.

For a fuller clinical picture of precipitated withdrawal and the COWS scoring that prevents it, see our article on Nervous About Starting Suboxone.

Once You’re Inducted: What the First Week Looks Like

Assuming the timing works, the first buprenorphine dose produces noticeable relief within 30 to 90 minutes. The physical symptoms you came in with quiet. Cravings drop sharply. Sleep, which is often wrecked during 7-OH withdrawal, starts to return.

Expected first-week milestones:

  • Day 1–2: Dose titration. Most 7-OH patients stabilize at a lower Suboxone dose than heroin or fentanyl patients, but individual response varies. A couple of phone or in-person touchpoints is normal.
  • Day 3–7: Mild side effects — headache, constipation, sometimes nausea — typically resolve by the end of this window. Cravings should be substantially quieter. Sleep continues to normalize.
  • End of week 1: First follow-up visit. Your provider confirms stability, discusses next steps — whether to stay on daily Suboxone or transition to a long-acting injection like Sublocade (monthly) or Brixadi (weekly, bi-weekly, or monthly).
  • Week 2+: Mood, energy, and motivation continue to improve as brain chemistry normalizes. Counseling and peer support become more productive because you’re not burning cycles on withdrawal management.

Why Daily Dosing vs. Injection Is Worth Thinking About

For 7-OH patients specifically, the long-acting injection options are often a strong fit. The pattern that reinforced your 7-OH use — dose, wait, feel the gap, dose again, sometimes four or five times a day — doesn’t map onto a monthly Sublocade injection at all. Many patients find that removing the dosing decision entirely is more stabilizing than replacing it with daily Suboxone.

You don’t have to decide on day one. Starting on Suboxone and moving to an injection after a couple of weeks of stability is a common path. Some patients stay on daily dosing long-term and that’s fine too.

What About Going Back to 7-OH While on Suboxone?

Buprenorphine occupies the mu-opioid receptor tightly and at high proportion, which means 7-OH used on top of a stable Suboxone dose typically produces little to no effect. For most patients this is welcome — the medication puts a ceiling on relapse potency. A single slip is unlikely to produce the high that would reinforce the pattern.

That said, dosing around Suboxone with the goal of feeling 7-OH isn’t safe and doesn’t accomplish the goal; it creates unpredictability, increases overdose risk if you take enough to overcome the buprenorphine, and undermines the stabilization the medication is providing. Talk to your counselor if slips happen — this is treatment, not a pass/fail test.

What the First Call Looks Like

When you call 423-498-2000 or submit a contact request, our intake team will:

  • Ask what 7-OH products you’ve been using, how much, and how often.
  • Ask when your last dose was.
  • Verify your insurance benefits.
  • Schedule your first visit (same-week availability at all four clinic locations).
  • Give you specific guidance about when to take your last dose of 7-OH before the appointment.

You don’t need to stop before you call. You don’t need to have your schedule figured out. Call with whatever information you have, and we’ll build the plan together.

Related Reading